Animal Parasiticides Market by Type (Ectoparasiticide, Endoparasiticide, Endectocide, Spray, Feed Additives), Animal Type (Dog, Cat, Horse, Cattle, Pig, Poultry), End user (Hospital, Animal farm, Home Care Setting) & Region - Global Forecast to 2031
The animal parasiticides market is expected to grow from USD 12.98 billion in 2026 to USD 17.50 billion by 2031, at a CAGR of 6.2%. This growth is driven by several key factors shaping the future of parasite prevention, including long-acting treatment solutions and precision-driven parasite management in veterinary care.
One of the most significant driving forces in the animal parasiticides market is the growing demand for more effective, targeted, and preventive parasite control strategies as veterinary healthcare professionals work to improve the accuracy, speed, and longevity of parasite control. As the trend in the companion animal healthcare industry continues to evolve to a data-driven and risk-based approach to parasite control, there is an increasing demand for high-quality parasiticides that can support precision dosing, resistance, and year-round protection. This has been further fueled by the use of analytics and digital health platforms, thus creating a demand for innovative and safe parasiticide products.
Pet owners face urgent demand for fast-acting, effective, and long-lasting solutions because parasite infestations, vector-borne diseases, and age-related pet vulnerability keep increasing in frequency. Veterinarians use advanced oral, topical, and injectable products to treat more patients while achieving better treatment results through reduced need for patient follow-ups. The rising parasite resistance problem and environmental parasite contamination issue compel scientists to develop new active ingredients and combination parasiticides for their research.
Formulation science and delivery system advancements, such as extended-release injectables, long-acting oral chewables, and enhanced topical formulations, are driving the market as they enhance efficacy, ease of use, and compliance. Such advancements enable effective preventive treatment, close treatment gaps, and improve real-world outcomes, thus accelerating the ongoing development and adoption of innovative solutions in the animal parasiticides market.
“By animal type, the companion animals segment is projected to exhibit a higher CAGR than the livestock segment during the forecast period.”
The companion animals segment is expected to experience a high growth rate in the animal parasiticides market because of the rising number of pet owners, the increasing humanization of pets, and increased expenditures on preventive veterinary care. The growing awareness of parasite-borne diseases, combined with the strong adoption of year-round flea, tick, and heartworm prevention and innovative long-acting parasiticide products, has also fueled demand in this segment.
“By end user, the veterinary hospitals & clinics segment accounted for the largest market share in 2025.”
In 2025, the veterinary hospitals & clinics segment dominated the animal parasiticides market because these facilities served as the main center for parasite control treatment delivery through their diagnostic and prescription capabilities. Pet owners and livestock producers depend on veterinarians to deliver expert product advice and preventive care solutions, which leads to increased sales of parasiticides at veterinary clinics. The combination of prescription-only products and advanced long-acting products, together with rising demand for routine check-ups and preventive care, has established veterinary hospitals and clinics as the primary distribution and treatment channel in the market.
“Latin America is expected to witness the highest growth rate during the forecast period.”
Latin America is projected to be the fastest-growing regional market for animal parasiticides during the forecast period. The region's high market growth can be attributed to the expansion of livestock production, the increase in companion animal ownership, and a growing awareness of parasite prevention and animal health. Year-round favorable parasite living conditions due to the region's climate, enhanced availability of veterinary services, and increased use of modern parasiticide products are all factors that are speeding up the market growth in the Latin American region.
Breakdown of supply-side primary interviews:
The market study covers the animal parasiticides market in various segments. It aims to estimate the size and growth potential of this market by type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
One of the most significant driving forces in the animal parasiticides market is the growing demand for more effective, targeted, and preventive parasite control strategies as veterinary healthcare professionals work to improve the accuracy, speed, and longevity of parasite control. As the trend in the companion animal healthcare industry continues to evolve to a data-driven and risk-based approach to parasite control, there is an increasing demand for high-quality parasiticides that can support precision dosing, resistance, and year-round protection. This has been further fueled by the use of analytics and digital health platforms, thus creating a demand for innovative and safe parasiticide products.
Pet owners face urgent demand for fast-acting, effective, and long-lasting solutions because parasite infestations, vector-borne diseases, and age-related pet vulnerability keep increasing in frequency. Veterinarians use advanced oral, topical, and injectable products to treat more patients while achieving better treatment results through reduced need for patient follow-ups. The rising parasite resistance problem and environmental parasite contamination issue compel scientists to develop new active ingredients and combination parasiticides for their research.
Formulation science and delivery system advancements, such as extended-release injectables, long-acting oral chewables, and enhanced topical formulations, are driving the market as they enhance efficacy, ease of use, and compliance. Such advancements enable effective preventive treatment, close treatment gaps, and improve real-world outcomes, thus accelerating the ongoing development and adoption of innovative solutions in the animal parasiticides market.
“By animal type, the companion animals segment is projected to exhibit a higher CAGR than the livestock segment during the forecast period.”
The companion animals segment is expected to experience a high growth rate in the animal parasiticides market because of the rising number of pet owners, the increasing humanization of pets, and increased expenditures on preventive veterinary care. The growing awareness of parasite-borne diseases, combined with the strong adoption of year-round flea, tick, and heartworm prevention and innovative long-acting parasiticide products, has also fueled demand in this segment.
“By end user, the veterinary hospitals & clinics segment accounted for the largest market share in 2025.”
In 2025, the veterinary hospitals & clinics segment dominated the animal parasiticides market because these facilities served as the main center for parasite control treatment delivery through their diagnostic and prescription capabilities. Pet owners and livestock producers depend on veterinarians to deliver expert product advice and preventive care solutions, which leads to increased sales of parasiticides at veterinary clinics. The combination of prescription-only products and advanced long-acting products, together with rising demand for routine check-ups and preventive care, has established veterinary hospitals and clinics as the primary distribution and treatment channel in the market.
“Latin America is expected to witness the highest growth rate during the forecast period.”
Latin America is projected to be the fastest-growing regional market for animal parasiticides during the forecast period. The region's high market growth can be attributed to the expansion of livestock production, the increase in companion animal ownership, and a growing awareness of parasite prevention and animal health. Year-round favorable parasite living conditions due to the region's climate, enhanced availability of veterinary services, and increased use of modern parasiticide products are all factors that are speeding up the market growth in the Latin American region.
Breakdown of supply-side primary interviews:
- By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
- By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
- By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%)
- By End User: Veterinary Hospitals & Clinics (50%), Animal Farms (33%), and Home Care Settings (17%)
- By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)
The market study covers the animal parasiticides market in various segments. It aims to estimate the size and growth potential of this market by type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger market share. Firms that acquire the report can implement one or more of the five strategies outlined below.
This report provides insights into the following points:
- Analysis of key drivers (rising pet ownership and increased focus on preventive animal healthcare and growing prevalence of ecto- and endoparasites), restraints (strict regulations on parasiticide residues in food-producing animals and high cost of premium and combination parasiticide products), opportunities (development of long-acting, combination, and novel-delivery parasiticides and expansion of parasiticide adoption in emerging markets), and challenges (increasing parasite resistance to existing active ingredients and stringent regulatory approval processes and varying regional compliance requirements) influencing the growth of the animal parasiticides market.
- Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the animal parasiticides market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of animal parasiticide products across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the animal parasiticides market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the animal parasiticides market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN ANIMAL PARASITICIDES MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 ANIMAL PARASITICIDES MARKET OVERVIEW
3.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2025)
3.3 ANIMAL PARASITICIDES MARKET: REGIONAL GROWTH OPPORTUNITIES
3.4 ANIMAL PARASITICIDES MARKET: REGION (2026?2031)
3.5 ANIMAL PARASITICIDES MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing zoonotic & vector-borne disease burden, creating mandatory treatment
4.2.1.2 Expanding companion animal population and pet ownership
4.2.1.3 Increasing demand for animal-derived food products
4.2.2 RESTRAINTS
4.2.2.1 Growing resistance to parasiticides
4.2.2.2 Stringent regulatory approval processes for veterinary drugs
4.2.3 OPPORTUNITIES
4.2.3.1 High growth potential of emerging economies
4.2.4 CHALLENGES
4.2.4.1 Uneven regulatory approval timelines across key markets, creating access inequalities
4.2.4.2 Balancing animal welfare, productivity, and compliance requirements
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKET AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCE ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 GDP, CURRENT PRICES (BILLIONS OF U.S. DOLLARS)
5.2.4 GDP: CURRENT PRICES (USD BILLION)
5.2.5 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY
5.2.6 TRENDS IN GLOBAL ANIMAL PARASITICIDES INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY KEY PLAYER, 2023–2025
5.5.1.1 Average selling price trend of ectoparasiticides, by key player, 2023?2025
5.5.1.2 Average selling price trend of endoparasiticides, by key player, 2023?2025
5.5.1.3 Average selling price trend of endectocides, by key player, 2023?2025
5.5.2 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY REGION, 2023–2025
5.5.2.1 Average selling price trend of pour-on ectoparasiticides (USD per standard treatment unit), by region, 2023?2025
5.5.2.2 Average selling price trend of spray ectoparasiticides (USD per standard treatment unit), by region, 2023?2025
5.5.2.3 Average selling price trend of tablet ectoparasiticides (USD per standard treatment unit), by region, 2023?2025
5.5.2.4 Average selling price trend of endoparasiticide oral solids (USD per standard treatment unit), by region, 2023?2025
5.5.2.5 Average selling price trend of injectable endectocides (USD per standard treatment unit), by region, 2023?2025
5.6 TRADE ANALYSIS
5.6.1 IMPORT DATA FOR HS CODE 30, 2021–2025
5.6.2 IMPORT SCENARIO (HS CODE 30)
5.6.3 EXPORT DATA FOR HS CODE 30, 2021–2025
5.6.4 EXPORT SCENARIO (HS CODE 30)
5.7 KEY CONFERENCES AND EVENTS IN 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY 1: BROAD-SPECTRUM COMBINATION ECTOPARASITICIDE + ENDOPARASITICIDE (ZOETIS – SIMPARICA TRIO)
5.10.2 CASE STUDY 2: FIRST BROAD-SPECTRUM FELINE TOPICAL ENDECTOCIDE (BOEHRINGER INGELHEIM – NEXGARD COMBO)
5.10.3 CASE STUDY 3: BROADEST-SPECTRUM CANINE ORAL PARASITICIDE WITH FOUR ACTIVE INGREDIENTS (ELANCO – CREDELIO QUATTRO)
5.11 ANIMAL PARASITICIDES MARKET: IMPACT OF 2025 US TARIFF
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.5 IMPACT ON END USERS
5.11.5.1 Veterinary hospitals & clinics
5.11.5.2 Home care settings
5.11.5.3 Animal farms
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY EMERGING TECHNOLOGIES
6.1.1.1 Long-acting/Extended-release parasiticides
6.1.1.2 Novel multi-parasite combination therapies
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 Immunomodulators for host-assisted parasitic control
6.1.2.2 Nanobiosensors and rapid diagnostics for parasitic detection
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Entomopathogenic Fungi (EPF) for ticks and ectoparasites
6.1.3.2 Precision livestock farming sensors and wearables
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 PUBLICATION TRENDS FOR ANIMAL PARASITICIDES
6.3.1.1 Insights on patent publication trends, top applicants and jurisdiction for animal parasiticides, january 2015–may 2026
6.3.2 LIST OF MAJOR PATENTS, 2023–2026
6.4 FUTURE APPLICATIONS
6.4.1 PRECISION LIVESTOCK HEALTH MANAGEMENT
6.4.2 ONCOLOGY AND CHRONIC DISEASE MANAGEMENT
6.4.3 REPRODUCTIVE AND FERTILITY ENHANCEMENT IN LIVESTOCK
6.4.4 INTEGRATED DISEASE SURVEILLANCE AND OUTBREAK CONTROL
6.5 IMPACT OF AI/GENERATIVE AI ON ANIMAL PARASITICIDES MARKET
6.5.1 INTRODUCTION
6.5.2 MARKET POTENTIAL IN ANIMAL PARASITICIDES ECOSYSTEM
6.5.3 AI USE CASES
6.5.4 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
7.1 DECISION-MAKING PROCESS
7.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
7.2.2 BUYING CRITERIA
7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
7.4 UNMET NEEDS IN VARIOUS END-USE SETTINGS
7.4.1 VETERINARY HOSPITALS & CLINICS
7.4.2 LIVESTOCK FARMS
7.4.3 HOME CARE SETTINGS
7.5 MARKET PROFITABILITY
7.5.1 PRODUCT INNOVATION AND DIFFERENTIATION
7.5.2 EXPANSION OF COMPANION ANIMAL HEALTHCARE SPENDING
7.5.3 OPERATIONAL SCALE AND DISTRIBUTION EFFICIENCY
8 SUSTAINABILITY AND REGULATORY LANDSCAPE
8.1 REGULATORY LANDSCAPE
8.1.1 REGULATORY FRAMEWORK
8.1.1.1 North America
8.1.1.2 Europe
8.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.1.3 INDUSTRY STANDARDS
8.1.3.1 VICH Guidelines (International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products)
8.1.3.2 Good Manufacturing Practice (GMP) Standards – PIC/S Guide (PE 009 series)
8.1.3.3 Codex Alimentarius Standards for Veterinary Drug Residues (CXM 2 – Maximum Residue Limits)
8.2 SUSTAINABILITY INITIATIVES
8.2.1 ENERGY-EFFICIENT MANUFACTURING & CARBON REDUCTION IN ANIMAL PARASITICIDES MARKET
8.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
9 ANIMAL PARASITICIDES MARKET, BY TYPE
9.1 INTRODUCTION
9.2 ECTOPARASITICIDES
9.2.1 POUR-ONS & SPOT-ONS
9.2.1.1 Ease of application and broad spectrum activity to drive continued adoption
9.2.1.2 Global volume analysis of pour-ons & spot-ons, 2024–2031 (Thousand Units)
9.2.2 ORAL TABLETS
9.2.2.1 High medication compliance and ease of administration to drive market
9.2.2.2 Global Volume Analysis of oral tablets, 2024–2031 (Thousand Units)
9.2.3 SPRAYS
9.2.3.1 Low price and convenience to drive market in emerging economies and livestock sector
9.2.3.2 Global Volume Analysis of sprays, 2024–2031 (Thousand Units)
9.2.4 DIPS
9.2.4.1 High popularity ensures sustained end-user demand
9.2.4.2 Global Volume Analysis of DIPS, 2024–2031 (Thousand Units)
9.2.5 EAR TAGS
9.2.5.1 High effectiveness in controlling flies around cattle drives market
9.2.5.2 Global Volume Analysis of ear tags, 2024–2031 (Thousand Units)
9.2.6 COLLARS
9.2.6.1 Growing prevalence of infections in companion animals to drive adoption
9.2.6.2 Global Volume Analysis of collars market, 2024–2031
(Thousand Units)
9.2.7 OTHER ECTOPARASITICIDES
9.3 ENDOPARASITICIDES
9.3.1 ORAL LIQUIDS
9.3.1.1 Broad-spectrum activity to drive adoption across young animals and intensive livestock systems
9.3.1.2 Global volume analysis of oral liquids, 2024–2031 (Thousand Units)
9.3.2 ORAL SOLIDS
9.3.2.1 Emergence of internal parasitic infections in dogs to drive market
9.3.2.2 Global volume analysis of oral solids, 2024–2031 (Thousand Units)
9.3.3 INJECTABLES
9.3.3.1 Global volume analysis of injectables, 2024–2031 (Thousand Units)
9.3.3.2 Standard/Short-acting injectables
9.3.3.2.1 Veterinary preference for fast-acting injectable formulations in acute parasitic infections drives market growth
9.3.3.3 Long-acting/Extended-release injectables
9.3.3.3.1 Emergence of internal parasitic infections in dogs to drive market
9.3.4 FEED ADDITIVES
9.3.4.1 Can be administered to large number of animals at once
9.3.4.2 Global volume analysis of feed additives, 2024–2031 (Thousand Units)
9.3.5 OTHER ENDOPARASITICIDES
9.4 ENDECTOCIDES
9.4.1 ORAL ENDECTOCIDES
9.4.1.1 Growing pet owner preference for systemic all-in-one protection to accelerate oral endectocide demand
9.4.1.2 Global volume analysis of oral endectocides, 2024–2031 (Thousand Units)
9.4.2 INJECTABLE ENDECTOCIDES
9.4.2.1 Single-injection dual-action convenience underpins dominance in cattle and swine production systems
9.4.2.2 Global volume analysis of injectable endectocides, 2024–2031 (Thousand Units)
9.4.3 TOPICAL ENDECTOCIDES
9.4.3.1 Convenience, zero-injection compliance, and expanding multi-spectrum topical formulations sustain demand
9.4.3.2 Global volume analysis of topical endectocides, 2024–2031 (Thousand Units)
10 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE
10.1 INTRODUCTION
10.2 COMPANION ANIMALS
10.2.1 DOGS
10.2.1.1 Increasing adoption of dogs to drive market growth
10.2.2 CATS
10.2.2.1 Rising feline parasiticide adoption, low preventive compliance, and broad-spectrum product launches drive growth
10.2.3 HORSES
10.2.3.1 Higher risk of traumatic injuries in horses to drive demand
10.2.4 OTHER COMPANION ANIMALS
10.3 LIVESTOCK ANIMALS
10.3.1 CATTLE
10.3.1.1 Gastrointestinal nematodes and tick-borne disease drive systemic endectocide and acaricide demand
10.3.2 PIG
10.3.2.1 Growing surgical volume for acute conditions in swine to drive market growth
10.3.3 POULTRY
10.3.3.1 Growing focus on infection prevention and flock health management propels growth
10.3.4 SHEEP & GOAT
10.3.4.1 Growth in consumption of sheep and goat meat to drive market
10.3.5 OTHER LIVESTOCK ANIMALS
11 ANIMAL PARASITICIDES MARKET, BY END USER
11.1 INTRODUCTION
11.2 VETERINARY HOSPITALS & CLINICS
11.2.1 VETERINARY HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
11.3 ANIMAL FARMS
11.3.1 GROWING IMPORTANCE AND OPPORTUNITIES IN ON-FARM PARASITE MANAGEMENT
11.4 HOME CARE SETTINGS
11.4.1 RISING PET EXPENDITURE TO PROPEL MARKET GROWTH
12 ANIMAL PARASITICIDES MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.2.3 US
12.2.3.1 Surge in animal healthcare expenditure to boost market growth
12.2.4 CANADA
12.2.4.1 Growing pet ownership and increasing focus on preventive animal healthcare to drive market growth
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.3.3 GERMANY
12.3.3.1 Strong focus on animal welfare and advanced veterinary care to drive market growth
12.3.4 UK
12.3.4.1 Increasing pet ownership and rising animal healthcare spending to propel market growth
12.3.5 FRANCE
12.3.5.1 High standards of veterinary care and technological advancements to support market growth
12.3.6 ITALY
12.3.6.1 Growing pet ownership awareness and increasing livestock population to drive market growth
12.3.7 SPAIN
12.3.7.1 Increasing awareness regarding animal health to drive market growth
12.3.8 NETHERLANDS
12.3.8.1 Growing pet ownership and strong livestock sector to support market growth
12.3.9 SWEDEN
12.3.9.1 Growing companion animal care and advanced veterinary infrastructure supporting market growth
12.3.10 POLAND
12.3.10.1 Rapid expansion of poultry production and export-oriented farming increases demand
12.3.11 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.4.3 CHINA
12.4.3.1 China to register highest growth rate during forecast period
12.4.4 JAPAN
12.4.4.1 Rising pet care expenditure and increasing adoption of companion animals to drive market growth
12.4.5 INDIA
12.4.5.1 Increasing livestock population to propel market growth
12.4.6 AUSTRALIA
12.4.6.1 Growing companion animal ownership and rise in animal health awareness to support market growth
12.4.7 SOUTH KOREA
12.4.7.1 Growing pet ownership to favor growth
12.4.8 THAILAND
12.4.8.1 Growing focus on livestock health and disease prevention to drive market growth
12.4.9 NEW ZEALAND
12.4.9.1 Growing pet ownership and focus on preventive animal healthcare to support market growth
12.4.10 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.5.3 BRAZIL
12.5.3.1 Brazil to dominate Latin American market
12.5.4 MEXICO
12.5.4.1 Robust livestock base and growing companion animal care drive market
12.5.5 ARGENTINA
12.5.5.1 Expanding livestock production and increasing focus on disease prevention to drive market growth
12.5.6 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.7 GCC COUNTRIES
12.7.1 KINGDOM OF SAUDI ARABIA (KSA)
12.7.1.1 Market growth driven by Vision 2030 investments
12.7.2 UNITED ARAB EMIRATES (UAE)
12.7.2.1 Increasing focus on livestock health and companion animal care to support market growth
12.7.3 OTHER GCC COUNTRIES
12.7.4 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET
13.2 REVENUE ANALYSIS, 2023–2025
13.3 GLOBAL MARKET SHARE ANALYSIS, 2025
13.3.1 US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
13.3.2 EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
13.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
13.4.1 STARS
13.4.2 EMERGING LEADERS
13.4.3 PERVASIVE PLAYERS
13.4.4 PARTICIPANTS
13.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.4.5.1 Company footprint
13.4.5.2 Region footprint
13.4.5.3 Product type footprint
13.4.5.4 Animal type footprint
13.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.5.1 PROGRESSIVE COMPANIES
13.5.2 RESPONSIVE COMPANIES
13.5.3 DYNAMIC COMPANIES
13.5.4 STARTING BLOCKS
13.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.5.5.1 List of startups/SMEs
13.5.5.2 Competitive benchmarking of startups/SMEs
13.6 COMPANY VALUATION AND FINANCIAL METRICS
13.7 PRODUCT/BRAND COMPARISON
13.8 COMPETITIVE SITUATIONS & TRENDS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 ZOETIS INC.
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches & approvals
14.1.1.3.2 Expansions
14.1.1.3.3 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses and competitive threats
14.1.2 MERCK & CO., INC
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches & approvals
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches & approvals
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 ELANCO
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches & approvals
14.1.4.3.2 Expansions
14.1.4.3.3 Other developments
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses and competitive threats
14.1.5 VIRBAC
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches & approvals
14.1.5.3.2 Deal
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 CEVA
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.6.3.2 Expansions
14.1.7 VETOQUINOL
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.8 NORBROOK
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches & approvals
14.1.8.3.2 Expansions
14.1.9 BIMEDA CORPORATE
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Product launches & approvals
14.1.9.3.2 Deals
14.1.9.3.3 Expansions
14.1.10 KYORITSU SEIYAKU CORPORATION
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.11 KRKA, D. D., NOVO MESTO
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 ECO - ANIMAL HEALTH LTD.
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 ALIVIRA ANIMAL HEALTH LIMITED
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.2.1 Recent developments
14.1.13.2.2 Deals
14.1.14 OUROFINO SA?DE ANIMAL
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 HEBEI VEYONG PHARMACEUTICAL CO., LTD.
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 CHANELLE PHARMA
14.2.2 PETIQ LLC
14.2.3 HUVEPHARMA
14.2.4 CALIER
14.2.5 ABBEY LABS
14.2.6 BIOG?NESIS BAG?
14.2.7 VETANCO SA
14.2.8 HESTER BIOSCIENCES LIMITED
14.2.9 BRILLIANT BIO PHARMA
14.2.10 ASHISH LIFE SCIENCE
15 RESEARCH METHODOLOGY
15.1 RESEARCH APPROACH
15.2 RESEARCH METHODOLOGY DESIGN
15.2.1 SECONDARY RESEARCH
15.2.1.1 Key data from secondary sources
15.2.2 PRIMARY DATA
15.2.2.1 Key data from primary sources
15.2.2.2 Key industry insights
15.3 MARKET SIZE ESTIMATION
15.3.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
15.3.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
15.3.3 APPROACH 3: DEMAND-SIDE ANALYSIS
15.3.4 APPROACH 4: TOP-DOWN APPROACH
15.3.5 APPROACH 5: BOTTOM-UP APPROACH
15.4 MARKET BREAKDOWN & DATA TRIANGULATION
15.5 MARKET SHARE ESTIMATION
15.6 RESEARCH ASSUMPTIONS
15.7 RISK ASSESSMENT
15.8 RESEARCH LIMITATIONS
15.8.1 METHODOLOGY-RELATED LIMITATIONS
15.8.2 SCOPE-RELATED LIMITATIONS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.3.1 PRODUCT ANALYSIS
16.3.2 COMPANY INFORMATION
16.3.3 GEOGRAPHIC ANALYSIS
16.3.4 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
16.3.5 BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
16.3.6 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY
1.5 STAKEHOLDERS
2 EXECUTIVE SUMMARY
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN ANIMAL PARASITICIDES MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST
3 PREMIUM INSIGHTS
3.1 ANIMAL PARASITICIDES MARKET OVERVIEW
3.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET, BY TYPE AND COUNTRY (2025)
3.3 ANIMAL PARASITICIDES MARKET: REGIONAL GROWTH OPPORTUNITIES
3.4 ANIMAL PARASITICIDES MARKET: REGION (2026?2031)
3.5 ANIMAL PARASITICIDES MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.1.1 Increasing zoonotic & vector-borne disease burden, creating mandatory treatment
4.2.1.2 Expanding companion animal population and pet ownership
4.2.1.3 Increasing demand for animal-derived food products
4.2.2 RESTRAINTS
4.2.2.1 Growing resistance to parasiticides
4.2.2.2 Stringent regulatory approval processes for veterinary drugs
4.2.3 OPPORTUNITIES
4.2.3.1 High growth potential of emerging economies
4.2.4 CHALLENGES
4.2.4.1 Uneven regulatory approval timelines across key markets, creating access inequalities
4.2.4.2 Balancing animal welfare, productivity, and compliance requirements
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKET AND CROSS-SECTOR OPPORTUNITIES
4.4.1 INTERCONNECTED MARKETS
4.4.2 CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5 INDUSTRY TRENDS
5.1 PORTER’S FIVE FORCE ANALYSIS
5.1.1 THREAT OF NEW ENTRANTS
5.1.2 THREAT OF SUBSTITUTES
5.1.3 BARGAINING POWER OF SUPPLIERS
5.1.4 BARGAINING POWER OF BUYERS
5.1.5 INTENSITY OF COMPETITIVE RIVALRY
5.2 MACROECONOMIC INDICATORS
5.2.1 INTRODUCTION
5.2.2 GDP TRENDS AND FORECAST
5.2.3 GDP, CURRENT PRICES (BILLIONS OF U.S. DOLLARS)
5.2.4 GDP: CURRENT PRICES (USD BILLION)
5.2.5 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY
5.2.6 TRENDS IN GLOBAL ANIMAL PARASITICIDES INDUSTRY
5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY KEY PLAYER, 2023–2025
5.5.1.1 Average selling price trend of ectoparasiticides, by key player, 2023?2025
5.5.1.2 Average selling price trend of endoparasiticides, by key player, 2023?2025
5.5.1.3 Average selling price trend of endectocides, by key player, 2023?2025
5.5.2 AVERAGE SELLING PRICE TREND OF ANIMAL PARASITICIDES, BY REGION, 2023–2025
5.5.2.1 Average selling price trend of pour-on ectoparasiticides (USD per standard treatment unit), by region, 2023?2025
5.5.2.2 Average selling price trend of spray ectoparasiticides (USD per standard treatment unit), by region, 2023?2025
5.5.2.3 Average selling price trend of tablet ectoparasiticides (USD per standard treatment unit), by region, 2023?2025
5.5.2.4 Average selling price trend of endoparasiticide oral solids (USD per standard treatment unit), by region, 2023?2025
5.5.2.5 Average selling price trend of injectable endectocides (USD per standard treatment unit), by region, 2023?2025
5.6 TRADE ANALYSIS
5.6.1 IMPORT DATA FOR HS CODE 30, 2021–2025
5.6.2 IMPORT SCENARIO (HS CODE 30)
5.6.3 EXPORT DATA FOR HS CODE 30, 2021–2025
5.6.4 EXPORT SCENARIO (HS CODE 30)
5.7 KEY CONFERENCES AND EVENTS IN 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.10.1 CASE STUDY 1: BROAD-SPECTRUM COMBINATION ECTOPARASITICIDE + ENDOPARASITICIDE (ZOETIS – SIMPARICA TRIO)
5.10.2 CASE STUDY 2: FIRST BROAD-SPECTRUM FELINE TOPICAL ENDECTOCIDE (BOEHRINGER INGELHEIM – NEXGARD COMBO)
5.10.3 CASE STUDY 3: BROADEST-SPECTRUM CANINE ORAL PARASITICIDE WITH FOUR ACTIVE INGREDIENTS (ELANCO – CREDELIO QUATTRO)
5.11 ANIMAL PARASITICIDES MARKET: IMPACT OF 2025 US TARIFF
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.5 IMPACT ON END USERS
5.11.5.1 Veterinary hospitals & clinics
5.11.5.2 Home care settings
5.11.5.3 Animal farms
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION
6.1 TECHNOLOGY ANALYSIS
6.1.1 KEY EMERGING TECHNOLOGIES
6.1.1.1 Long-acting/Extended-release parasiticides
6.1.1.2 Novel multi-parasite combination therapies
6.1.2 COMPLEMENTARY TECHNOLOGIES
6.1.2.1 Immunomodulators for host-assisted parasitic control
6.1.2.2 Nanobiosensors and rapid diagnostics for parasitic detection
6.1.3 ADJACENT TECHNOLOGIES
6.1.3.1 Entomopathogenic Fungi (EPF) for ticks and ectoparasites
6.1.3.2 Precision livestock farming sensors and wearables
6.2 TECHNOLOGY/PRODUCT ROADMAP
6.3 PATENT ANALYSIS
6.3.1 PUBLICATION TRENDS FOR ANIMAL PARASITICIDES
6.3.1.1 Insights on patent publication trends, top applicants and jurisdiction for animal parasiticides, january 2015–may 2026
6.3.2 LIST OF MAJOR PATENTS, 2023–2026
6.4 FUTURE APPLICATIONS
6.4.1 PRECISION LIVESTOCK HEALTH MANAGEMENT
6.4.2 ONCOLOGY AND CHRONIC DISEASE MANAGEMENT
6.4.3 REPRODUCTIVE AND FERTILITY ENHANCEMENT IN LIVESTOCK
6.4.4 INTEGRATED DISEASE SURVEILLANCE AND OUTBREAK CONTROL
6.5 IMPACT OF AI/GENERATIVE AI ON ANIMAL PARASITICIDES MARKET
6.5.1 INTRODUCTION
6.5.2 MARKET POTENTIAL IN ANIMAL PARASITICIDES ECOSYSTEM
6.5.3 AI USE CASES
6.5.4 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
7.1 DECISION-MAKING PROCESS
7.2 KEY STAKEHOLDERS AND BUYING EVALUATION CRITERIA
7.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
7.2.2 BUYING CRITERIA
7.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
7.4 UNMET NEEDS IN VARIOUS END-USE SETTINGS
7.4.1 VETERINARY HOSPITALS & CLINICS
7.4.2 LIVESTOCK FARMS
7.4.3 HOME CARE SETTINGS
7.5 MARKET PROFITABILITY
7.5.1 PRODUCT INNOVATION AND DIFFERENTIATION
7.5.2 EXPANSION OF COMPANION ANIMAL HEALTHCARE SPENDING
7.5.3 OPERATIONAL SCALE AND DISTRIBUTION EFFICIENCY
8 SUSTAINABILITY AND REGULATORY LANDSCAPE
8.1 REGULATORY LANDSCAPE
8.1.1 REGULATORY FRAMEWORK
8.1.1.1 North America
8.1.1.2 Europe
8.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8.1.3 INDUSTRY STANDARDS
8.1.3.1 VICH Guidelines (International Cooperation on Harmonization of Technical Requirements for Registration of Veterinary Medicinal Products)
8.1.3.2 Good Manufacturing Practice (GMP) Standards – PIC/S Guide (PE 009 series)
8.1.3.3 Codex Alimentarius Standards for Veterinary Drug Residues (CXM 2 – Maximum Residue Limits)
8.2 SUSTAINABILITY INITIATIVES
8.2.1 ENERGY-EFFICIENT MANUFACTURING & CARBON REDUCTION IN ANIMAL PARASITICIDES MARKET
8.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
8.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS
9 ANIMAL PARASITICIDES MARKET, BY TYPE
9.1 INTRODUCTION
9.2 ECTOPARASITICIDES
9.2.1 POUR-ONS & SPOT-ONS
9.2.1.1 Ease of application and broad spectrum activity to drive continued adoption
9.2.1.2 Global volume analysis of pour-ons & spot-ons, 2024–2031 (Thousand Units)
9.2.2 ORAL TABLETS
9.2.2.1 High medication compliance and ease of administration to drive market
9.2.2.2 Global Volume Analysis of oral tablets, 2024–2031 (Thousand Units)
9.2.3 SPRAYS
9.2.3.1 Low price and convenience to drive market in emerging economies and livestock sector
9.2.3.2 Global Volume Analysis of sprays, 2024–2031 (Thousand Units)
9.2.4 DIPS
9.2.4.1 High popularity ensures sustained end-user demand
9.2.4.2 Global Volume Analysis of DIPS, 2024–2031 (Thousand Units)
9.2.5 EAR TAGS
9.2.5.1 High effectiveness in controlling flies around cattle drives market
9.2.5.2 Global Volume Analysis of ear tags, 2024–2031 (Thousand Units)
9.2.6 COLLARS
9.2.6.1 Growing prevalence of infections in companion animals to drive adoption
9.2.6.2 Global Volume Analysis of collars market, 2024–2031
(Thousand Units)
9.2.7 OTHER ECTOPARASITICIDES
9.3 ENDOPARASITICIDES
9.3.1 ORAL LIQUIDS
9.3.1.1 Broad-spectrum activity to drive adoption across young animals and intensive livestock systems
9.3.1.2 Global volume analysis of oral liquids, 2024–2031 (Thousand Units)
9.3.2 ORAL SOLIDS
9.3.2.1 Emergence of internal parasitic infections in dogs to drive market
9.3.2.2 Global volume analysis of oral solids, 2024–2031 (Thousand Units)
9.3.3 INJECTABLES
9.3.3.1 Global volume analysis of injectables, 2024–2031 (Thousand Units)
9.3.3.2 Standard/Short-acting injectables
9.3.3.2.1 Veterinary preference for fast-acting injectable formulations in acute parasitic infections drives market growth
9.3.3.3 Long-acting/Extended-release injectables
9.3.3.3.1 Emergence of internal parasitic infections in dogs to drive market
9.3.4 FEED ADDITIVES
9.3.4.1 Can be administered to large number of animals at once
9.3.4.2 Global volume analysis of feed additives, 2024–2031 (Thousand Units)
9.3.5 OTHER ENDOPARASITICIDES
9.4 ENDECTOCIDES
9.4.1 ORAL ENDECTOCIDES
9.4.1.1 Growing pet owner preference for systemic all-in-one protection to accelerate oral endectocide demand
9.4.1.2 Global volume analysis of oral endectocides, 2024–2031 (Thousand Units)
9.4.2 INJECTABLE ENDECTOCIDES
9.4.2.1 Single-injection dual-action convenience underpins dominance in cattle and swine production systems
9.4.2.2 Global volume analysis of injectable endectocides, 2024–2031 (Thousand Units)
9.4.3 TOPICAL ENDECTOCIDES
9.4.3.1 Convenience, zero-injection compliance, and expanding multi-spectrum topical formulations sustain demand
9.4.3.2 Global volume analysis of topical endectocides, 2024–2031 (Thousand Units)
10 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE
10.1 INTRODUCTION
10.2 COMPANION ANIMALS
10.2.1 DOGS
10.2.1.1 Increasing adoption of dogs to drive market growth
10.2.2 CATS
10.2.2.1 Rising feline parasiticide adoption, low preventive compliance, and broad-spectrum product launches drive growth
10.2.3 HORSES
10.2.3.1 Higher risk of traumatic injuries in horses to drive demand
10.2.4 OTHER COMPANION ANIMALS
10.3 LIVESTOCK ANIMALS
10.3.1 CATTLE
10.3.1.1 Gastrointestinal nematodes and tick-borne disease drive systemic endectocide and acaricide demand
10.3.2 PIG
10.3.2.1 Growing surgical volume for acute conditions in swine to drive market growth
10.3.3 POULTRY
10.3.3.1 Growing focus on infection prevention and flock health management propels growth
10.3.4 SHEEP & GOAT
10.3.4.1 Growth in consumption of sheep and goat meat to drive market
10.3.5 OTHER LIVESTOCK ANIMALS
11 ANIMAL PARASITICIDES MARKET, BY END USER
11.1 INTRODUCTION
11.2 VETERINARY HOSPITALS & CLINICS
11.2.1 VETERINARY HOSPITALS & CLINICS TO DOMINATE MARKET DURING FORECAST PERIOD
11.3 ANIMAL FARMS
11.3.1 GROWING IMPORTANCE AND OPPORTUNITIES IN ON-FARM PARASITE MANAGEMENT
11.4 HOME CARE SETTINGS
11.4.1 RISING PET EXPENDITURE TO PROPEL MARKET GROWTH
12 ANIMAL PARASITICIDES MARKET, BY REGION
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
12.2.2 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.2.3 US
12.2.3.1 Surge in animal healthcare expenditure to boost market growth
12.2.4 CANADA
12.2.4.1 Growing pet ownership and increasing focus on preventive animal healthcare to drive market growth
12.3 EUROPE
12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
12.3.2 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.3.3 GERMANY
12.3.3.1 Strong focus on animal welfare and advanced veterinary care to drive market growth
12.3.4 UK
12.3.4.1 Increasing pet ownership and rising animal healthcare spending to propel market growth
12.3.5 FRANCE
12.3.5.1 High standards of veterinary care and technological advancements to support market growth
12.3.6 ITALY
12.3.6.1 Growing pet ownership awareness and increasing livestock population to drive market growth
12.3.7 SPAIN
12.3.7.1 Increasing awareness regarding animal health to drive market growth
12.3.8 NETHERLANDS
12.3.8.1 Growing pet ownership and strong livestock sector to support market growth
12.3.9 SWEDEN
12.3.9.1 Growing companion animal care and advanced veterinary infrastructure supporting market growth
12.3.10 POLAND
12.3.10.1 Rapid expansion of poultry production and export-oriented farming increases demand
12.3.11 REST OF EUROPE
12.4 ASIA PACIFIC
12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
12.4.2 ASIA PACIFIC: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.4.3 CHINA
12.4.3.1 China to register highest growth rate during forecast period
12.4.4 JAPAN
12.4.4.1 Rising pet care expenditure and increasing adoption of companion animals to drive market growth
12.4.5 INDIA
12.4.5.1 Increasing livestock population to propel market growth
12.4.6 AUSTRALIA
12.4.6.1 Growing companion animal ownership and rise in animal health awareness to support market growth
12.4.7 SOUTH KOREA
12.4.7.1 Growing pet ownership to favor growth
12.4.8 THAILAND
12.4.8.1 Growing focus on livestock health and disease prevention to drive market growth
12.4.9 NEW ZEALAND
12.4.9.1 Growing pet ownership and focus on preventive animal healthcare to support market growth
12.4.10 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
12.5.2 LATIN AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.5.3 BRAZIL
12.5.3.1 Brazil to dominate Latin American market
12.5.4 MEXICO
12.5.4.1 Robust livestock base and growing companion animal care drive market
12.5.5 ARGENTINA
12.5.5.1 Expanding livestock production and increasing focus on disease prevention to drive market growth
12.5.6 REST OF LATIN AMERICA
12.6 MIDDLE EAST & AFRICA
12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
12.6.2 MIDDLE EAST & AFRICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
12.7 GCC COUNTRIES
12.7.1 KINGDOM OF SAUDI ARABIA (KSA)
12.7.1.1 Market growth driven by Vision 2030 investments
12.7.2 UNITED ARAB EMIRATES (UAE)
12.7.2.1 Increasing focus on livestock health and companion animal care to support market growth
12.7.3 OTHER GCC COUNTRIES
12.7.4 REST OF MIDDLE EAST & AFRICA
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.1.1 KEY STRATEGIES ADOPTED BY PLAYERS IN ANIMAL PARASITICIDES MARKET
13.2 REVENUE ANALYSIS, 2023–2025
13.3 GLOBAL MARKET SHARE ANALYSIS, 2025
13.3.1 US ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
13.3.2 EUROPE ANIMAL PARASITICIDES MARKET SHARE ANALYSIS, 2025
13.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
13.4.1 STARS
13.4.2 EMERGING LEADERS
13.4.3 PERVASIVE PLAYERS
13.4.4 PARTICIPANTS
13.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
13.4.5.1 Company footprint
13.4.5.2 Region footprint
13.4.5.3 Product type footprint
13.4.5.4 Animal type footprint
13.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
13.5.1 PROGRESSIVE COMPANIES
13.5.2 RESPONSIVE COMPANIES
13.5.3 DYNAMIC COMPANIES
13.5.4 STARTING BLOCKS
13.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
13.5.5.1 List of startups/SMEs
13.5.5.2 Competitive benchmarking of startups/SMEs
13.6 COMPANY VALUATION AND FINANCIAL METRICS
13.7 PRODUCT/BRAND COMPARISON
13.8 COMPETITIVE SITUATIONS & TRENDS
14 COMPANY PROFILES
14.1 KEY PLAYERS
14.1.1 ZOETIS INC.
14.1.1.1 Business overview
14.1.1.2 Products offered
14.1.1.3 Recent developments
14.1.1.3.1 Product launches & approvals
14.1.1.3.2 Expansions
14.1.1.3.3 Other developments
14.1.1.4 MnM view
14.1.1.4.1 Right to win
14.1.1.4.2 Strategic choices
14.1.1.4.3 Weaknesses and competitive threats
14.1.2 MERCK & CO., INC
14.1.2.1 Business overview
14.1.2.2 Products offered
14.1.2.3 Recent developments
14.1.2.3.1 Product launches & approvals
14.1.2.3.2 Deals
14.1.2.3.3 Expansions
14.1.2.4 MnM view
14.1.2.4.1 Right to win
14.1.2.4.2 Strategic choices
14.1.2.4.3 Weaknesses and competitive threats
14.1.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
14.1.3.1 Business overview
14.1.3.2 Products offered
14.1.3.3 Recent developments
14.1.3.3.1 Product launches & approvals
14.1.3.3.2 Deals
14.1.3.3.3 Expansions
14.1.3.4 MnM view
14.1.3.4.1 Right to win
14.1.3.4.2 Strategic choices
14.1.3.4.3 Weaknesses and competitive threats
14.1.4 ELANCO
14.1.4.1 Business overview
14.1.4.2 Products offered
14.1.4.3 Recent developments
14.1.4.3.1 Product launches & approvals
14.1.4.3.2 Expansions
14.1.4.3.3 Other developments
14.1.4.4 MnM view
14.1.4.4.1 Right to win
14.1.4.4.2 Strategic choices
14.1.4.4.3 Weaknesses and competitive threats
14.1.5 VIRBAC
14.1.5.1 Business overview
14.1.5.2 Products offered
14.1.5.3 Recent developments
14.1.5.3.1 Product launches & approvals
14.1.5.3.2 Deal
14.1.5.4 MnM view
14.1.5.4.1 Right to win
14.1.5.4.2 Strategic choices
14.1.5.4.3 Weaknesses and competitive threats
14.1.6 CEVA
14.1.6.1 Business overview
14.1.6.2 Products offered
14.1.6.3 Recent developments
14.1.6.3.1 Deals
14.1.6.3.2 Expansions
14.1.7 VETOQUINOL
14.1.7.1 Business overview
14.1.7.2 Products offered
14.1.8 NORBROOK
14.1.8.1 Business overview
14.1.8.2 Products offered
14.1.8.3 Recent developments
14.1.8.3.1 Product launches & approvals
14.1.8.3.2 Expansions
14.1.9 BIMEDA CORPORATE
14.1.9.1 Business overview
14.1.9.2 Products offered
14.1.9.3 Recent developments
14.1.9.3.1 Product launches & approvals
14.1.9.3.2 Deals
14.1.9.3.3 Expansions
14.1.10 KYORITSU SEIYAKU CORPORATION
14.1.10.1 Business overview
14.1.10.2 Products offered
14.1.11 KRKA, D. D., NOVO MESTO
14.1.11.1 Business overview
14.1.11.2 Products offered
14.1.12 ECO - ANIMAL HEALTH LTD.
14.1.12.1 Business overview
14.1.12.2 Products offered
14.1.13 ALIVIRA ANIMAL HEALTH LIMITED
14.1.13.1 Business overview
14.1.13.2 Products offered
14.1.13.2.1 Recent developments
14.1.13.2.2 Deals
14.1.14 OUROFINO SA?DE ANIMAL
14.1.14.1 Business overview
14.1.14.2 Products offered
14.1.15 HEBEI VEYONG PHARMACEUTICAL CO., LTD.
14.1.15.1 Business overview
14.1.15.2 Products offered
14.2 OTHER PLAYERS
14.2.1 CHANELLE PHARMA
14.2.2 PETIQ LLC
14.2.3 HUVEPHARMA
14.2.4 CALIER
14.2.5 ABBEY LABS
14.2.6 BIOG?NESIS BAG?
14.2.7 VETANCO SA
14.2.8 HESTER BIOSCIENCES LIMITED
14.2.9 BRILLIANT BIO PHARMA
14.2.10 ASHISH LIFE SCIENCE
15 RESEARCH METHODOLOGY
15.1 RESEARCH APPROACH
15.2 RESEARCH METHODOLOGY DESIGN
15.2.1 SECONDARY RESEARCH
15.2.1.1 Key data from secondary sources
15.2.2 PRIMARY DATA
15.2.2.1 Key data from primary sources
15.2.2.2 Key industry insights
15.3 MARKET SIZE ESTIMATION
15.3.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
15.3.2 APPROACH 2: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
15.3.3 APPROACH 3: DEMAND-SIDE ANALYSIS
15.3.4 APPROACH 4: TOP-DOWN APPROACH
15.3.5 APPROACH 5: BOTTOM-UP APPROACH
15.4 MARKET BREAKDOWN & DATA TRIANGULATION
15.5 MARKET SHARE ESTIMATION
15.6 RESEARCH ASSUMPTIONS
15.7 RISK ASSESSMENT
15.8 RESEARCH LIMITATIONS
15.8.1 METHODOLOGY-RELATED LIMITATIONS
15.8.2 SCOPE-RELATED LIMITATIONS
16 APPENDIX
16.1 DISCUSSION GUIDE
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3 CUSTOMIZATION OPTIONS
16.3.1 PRODUCT ANALYSIS
16.3.2 COMPANY INFORMATION
16.3.3 GEOGRAPHIC ANALYSIS
16.3.4 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT
16.3.5 BY TYPE MARKET SHARE ANALYSIS (TOP 5 PLAYERS)
16.3.6 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS
16.4 RELATED REPORTS
16.5 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2025
TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION
TABLE 4 TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED & EMERGING ECONOMIES
TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 7 PARASITICIDES AND RESISTANT PARASITES
TABLE 8 UNMET CUSTOMER NEEDS AND WHITE SPACES IN ANIMAL PARASITICIDES MARKET.
TABLE 9 INTERCONNECTED MARKETS IN ANIMAL PARASITICIDES MARKET
TABLE 10 CROSS-SECTOR MARKETS IN ANIMAL PARASITICIDES MARKET
TABLE 11 ANIMAL PARASITICIDES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 12 AVERAGE SELLING PRICE TREND OF ECTOPARASITICIDES, BY KEY PLAYER, 2023–2025
TABLE 13 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDES, BY KEY PLAYER, 2023–2025
TABLE 14 AVERAGE SELLING PRICE TREND OF ENDECTOCIDES, BY KEY PLAYER, 2023–2025
TABLE 15 AVERAGE SELLING PRICE TREND OF POUR-ON ECTOPARASITICIDES, BY REGION, 2023?2025
TABLE 16 AVERAGE SELLING PRICE TREND OF SPRAY ECTOPARASITICIDES, BY REGION, 2023?2025
TABLE 17 AVERAGE SELLING PRICE TREND OF TABLET ECTOPARASITICIDES, BY REGION, 2023?2025
TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDE ORAL SOLIDS, BY REGION, 2023?2025
TABLE 19 AVERAGE SELLING PRICE TREND OF INJECTABLE ENDECTOCIDES, BY REGION, 2023?2025
TABLE 20 IMPORT DATA FOR HS CODE 30, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 21 EXPORT DATA FOR HS CODE 30, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 22 ANIMAL PARASITICIDES MARKET: KEY CONFERENCES AND EVENTS
TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 24 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 25 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 26 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
TABLE 27 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 28 ANIMAL PARASITICIDES MARKET: MAJOR PATENTS, JANUARY 2022–MAY 2026
TABLE 29 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET
TABLE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL PARASITICIDES
TABLE 31 KEY BUYING CRITERIA FOR CLASS OF DEVICES
TABLE 32 ANIMAL PARASITICIDES MARKET: UNMET NEEDS IN KEY END-USE SETTINGS
TABLE 33 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 34 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 35 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 36 REST OF WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 37 ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 38 COMPANION ANIMALS – FLEA & TICK BURDEN
TABLE 39 ECTOPARASITICIDES AVAILABLE IN MARKET
TABLE 40 ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 41 ECTOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 KEY PLAYERS PROVIDING POUR-ONS & SPOT-ONS
TABLE 43 GLOBAL VOLUME ANALYSIS OF POUR-ONS & SPOT-ONS, 2024–2031 (THOUSAND UNITS)
TABLE 44 POUR-ONS & SPOT-ONS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING ORAL TABLETS
TABLE 46 GLOBAL VOLUME ANALYSIS OF ORAL TABLETS, 2024–2031 (THOUSAND UNITS)
TABLE 47 ORAL TABLETS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 KEY PLAYERS PROVIDING SPRAYS
TABLE 49 GLOBAL VOLUME ANALYSIS OF SPRAYS, 2024–2031 (THOUSAND UNITS)
TABLE 50 SPRAYS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING DIPS
TABLE 52 GLOBAL VOLUME ANALYSIS OF DIPS, 2024–2031 (THOUSAND UNITS)
TABLE 53 DIPS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 KEY PLAYERS PROVIDING TAGS
TABLE 55 GLOBAL VOLUME ANALYSIS OF EAR TAGS, 2024–2031 (THOUSAND UNITS)
TABLE 56 EARTAG: ANIMAL PARASITICIDES TAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 KEY PLAYERS PROVIDING COLLARS
TABLE 58 GLOBAL VOLUME ANALYSIS OF COLLARS MARKET, 2024–2031 (THOUSAND UNITS)
TABLE 59 COLLARS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ENDOPARASITICIDES AVAILABLE IN MARKET
TABLE 62 ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 63 ENDOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 KEY PLAYERS PROVIDING ORAL LIQUIDS
TABLE 65 GLOBAL VOLUME ANALYSIS OF ORAL LIQUIDS, 2024–2031 (THOUSAND UNITS)
TABLE 66 ORAL LIQUIDS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 KEY PLAYERS PROVIDING ORAL SOLIDS
TABLE 68 GLOBAL VOLUME ANALYSIS OF ORAL SOLIDS, 2024–2031 (THOUSAND UNITS)
TABLE 69 ORAL: ANIMAL PARASITICIDES SOLIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 GLOBAL VOLUME ANALYSIS OF INJECTABLES, 2024–2031 (THOUSAND UNITS)
TABLE 71 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 72 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 KEY PLAYERS PROVIDING STANDARD/SHORT-ACTING INJECTABLES
TABLE 74 STANDARD/SHORT-ACTING INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 KEY PLAYERS PROVIDING LONG-ACTING/EXTENDED-RELEASE INJECTABLES
TABLE 76 LONG-ACTING/EXTENDED-RELEASE INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 KEY PLAYERS PROVIDING FEED ADDITIVES
TABLE 78 GLOBAL VOLUME ANALYSIS OF FEED ADDITIVES, 2024–2031 (THOUSAND UNITS)
TABLE 79 FEED ADDITIVES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET
TABLE 82 ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 ENDECTOCIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 KEY PLAYERS PROVIDING ORAL ENDECTOCIDES
TABLE 85 GLOBAL VOLUME ANALYSIS OF ORAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)
TABLE 86 ORAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 KEY PLAYERS PROVIDING INJECTABLE ENDECTOCIDES
TABLE 88 GLOBAL VOLUME ANALYSIS OF INJECTABLE ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)
TABLE 89 INJECTABLE ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 KEY PLAYERS PROVIDING TOPICAL ENDECTOCIDES
TABLE 91 GLOBAL VOLUME ANALYSIS OF TOPICAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)
TABLE 92 TOPICAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 94 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 PARASITICIDE APPLICATIONS ACROSS OTHER COMPANION ANIMAL SPECIES
TABLE 100 ANIMAL PARASITICIDES MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 ANIMAL PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 ANIMAL PARASITICIDES MARKET FOR PIG, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 ANIMAL PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 106 ANIMAL PARASITICIDES MARKET FOR SHEEP & GOAT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 ANIMAL PARASITICIDES MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 108 ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 109 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112 ANIMAL PARASITICIDES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 113 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
TABLE 114 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 119 NORTH AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 121 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 122 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 123 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 124 US: KEY MACROINDICATORS
TABLE 125 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 US: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127 US: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128 US: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 129 US: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 131 US: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 132 US: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 133 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 134 CANADA: KEY MACROINDICATORS
TABLE 135 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138 CANADA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 139 CANADA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 141 CANADA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 142 CANADA ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 143 CANADA ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 144 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
TABLE 145 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 148 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 150 EUROPE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 152 EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 153 EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 155 GERMANY: KEY MACROINDICATORS
TABLE 156 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 159 GERMANY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 160 GERMANY: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 162 GERMANY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 163 GERMANY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 164 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 165 UK: KEY MACROINDICATORS
TABLE 166 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 UK: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 170 UK: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 172 UK: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 173 UK: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 174 UK ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 175 FRANCE: KEY MACROINDICATORS
TABLE 176 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179 FRANCE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 180 FRANCE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 182 FRANCE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 183 FRANCE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 184 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185 ITALY: KEY MACROINDICATORS
TABLE 186 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189 ITALY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 190 ITALY: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 192 ITALY: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 193 ITALY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 194 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 195 SPAIN: KEY MACROINDICATORS
TABLE 196 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 SPAIN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 200 SPAIN: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 202 SPAIN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 203 SPAIN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 204 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 205 NETHERLANDS: KEY MACROINDICATORS
TABLE 206 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 NETHERLANDS: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 NETHERLANDS: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 210 NETHERLANDS: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 212 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 213 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 214 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 215 SWEDEN: KEY MACRO INDICATORS
TABLE 216 SWEDEN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 SWEDEN: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 218 SWEDEN: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219 SWEDEN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 220 SWEDEN: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 SWEDEN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 222 SWEDEN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 223 SWEDEN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 224 SWEDEN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 225 POLAND: KEY MACRO INDICATORS
TABLE 226 POLAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227 POLAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 POLAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229 POLAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 230 POLAND: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 POLAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 232 POLAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 233 POLAND ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 234 POLAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 1 STANDARD CURRENCY CONVERSION RATES (USD)
TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2025
TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION
TABLE 4 TRENDS IN CONSUMPTION OF MEAT & MILK IN DEVELOPED & EMERGING ECONOMIES
TABLE 5 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 6 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)
TABLE 7 PARASITICIDES AND RESISTANT PARASITES
TABLE 8 UNMET CUSTOMER NEEDS AND WHITE SPACES IN ANIMAL PARASITICIDES MARKET.
TABLE 9 INTERCONNECTED MARKETS IN ANIMAL PARASITICIDES MARKET
TABLE 10 CROSS-SECTOR MARKETS IN ANIMAL PARASITICIDES MARKET
TABLE 11 ANIMAL PARASITICIDES MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 12 AVERAGE SELLING PRICE TREND OF ECTOPARASITICIDES, BY KEY PLAYER, 2023–2025
TABLE 13 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDES, BY KEY PLAYER, 2023–2025
TABLE 14 AVERAGE SELLING PRICE TREND OF ENDECTOCIDES, BY KEY PLAYER, 2023–2025
TABLE 15 AVERAGE SELLING PRICE TREND OF POUR-ON ECTOPARASITICIDES, BY REGION, 2023?2025
TABLE 16 AVERAGE SELLING PRICE TREND OF SPRAY ECTOPARASITICIDES, BY REGION, 2023?2025
TABLE 17 AVERAGE SELLING PRICE TREND OF TABLET ECTOPARASITICIDES, BY REGION, 2023?2025
TABLE 18 AVERAGE SELLING PRICE TREND OF ENDOPARASITICIDE ORAL SOLIDS, BY REGION, 2023?2025
TABLE 19 AVERAGE SELLING PRICE TREND OF INJECTABLE ENDECTOCIDES, BY REGION, 2023?2025
TABLE 20 IMPORT DATA FOR HS CODE 30, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 21 EXPORT DATA FOR HS CODE 30, BY COUNTRY, 2021–2025 (USD THOUSAND)
TABLE 22 ANIMAL PARASITICIDES MARKET: KEY CONFERENCES AND EVENTS
TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES
TABLE 24 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS
TABLE 25 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS
TABLE 26 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS
TABLE 27 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS
TABLE 28 ANIMAL PARASITICIDES MARKET: MAJOR PATENTS, JANUARY 2022–MAY 2026
TABLE 29 KEY COMPANIES IMPLEMENTING AI IN ANIMAL PARASITICIDES MARKET
TABLE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ANIMAL PARASITICIDES
TABLE 31 KEY BUYING CRITERIA FOR CLASS OF DEVICES
TABLE 32 ANIMAL PARASITICIDES MARKET: UNMET NEEDS IN KEY END-USE SETTINGS
TABLE 33 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 34 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 35 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 36 REST OF WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 37 ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 38 COMPANION ANIMALS – FLEA & TICK BURDEN
TABLE 39 ECTOPARASITICIDES AVAILABLE IN MARKET
TABLE 40 ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 41 ECTOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 42 KEY PLAYERS PROVIDING POUR-ONS & SPOT-ONS
TABLE 43 GLOBAL VOLUME ANALYSIS OF POUR-ONS & SPOT-ONS, 2024–2031 (THOUSAND UNITS)
TABLE 44 POUR-ONS & SPOT-ONS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 45 KEY PLAYERS PROVIDING ORAL TABLETS
TABLE 46 GLOBAL VOLUME ANALYSIS OF ORAL TABLETS, 2024–2031 (THOUSAND UNITS)
TABLE 47 ORAL TABLETS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 48 KEY PLAYERS PROVIDING SPRAYS
TABLE 49 GLOBAL VOLUME ANALYSIS OF SPRAYS, 2024–2031 (THOUSAND UNITS)
TABLE 50 SPRAYS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 51 KEY PLAYERS PROVIDING DIPS
TABLE 52 GLOBAL VOLUME ANALYSIS OF DIPS, 2024–2031 (THOUSAND UNITS)
TABLE 53 DIPS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 54 KEY PLAYERS PROVIDING TAGS
TABLE 55 GLOBAL VOLUME ANALYSIS OF EAR TAGS, 2024–2031 (THOUSAND UNITS)
TABLE 56 EARTAG: ANIMAL PARASITICIDES TAGS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 57 KEY PLAYERS PROVIDING COLLARS
TABLE 58 GLOBAL VOLUME ANALYSIS OF COLLARS MARKET, 2024–2031 (THOUSAND UNITS)
TABLE 59 COLLARS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 60 OTHER ECTOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 61 ENDOPARASITICIDES AVAILABLE IN MARKET
TABLE 62 ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 63 ENDOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 64 KEY PLAYERS PROVIDING ORAL LIQUIDS
TABLE 65 GLOBAL VOLUME ANALYSIS OF ORAL LIQUIDS, 2024–2031 (THOUSAND UNITS)
TABLE 66 ORAL LIQUIDS: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 67 KEY PLAYERS PROVIDING ORAL SOLIDS
TABLE 68 GLOBAL VOLUME ANALYSIS OF ORAL SOLIDS, 2024–2031 (THOUSAND UNITS)
TABLE 69 ORAL: ANIMAL PARASITICIDES SOLIDS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 70 GLOBAL VOLUME ANALYSIS OF INJECTABLES, 2024–2031 (THOUSAND UNITS)
TABLE 71 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 72 INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 73 KEY PLAYERS PROVIDING STANDARD/SHORT-ACTING INJECTABLES
TABLE 74 STANDARD/SHORT-ACTING INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 75 KEY PLAYERS PROVIDING LONG-ACTING/EXTENDED-RELEASE INJECTABLES
TABLE 76 LONG-ACTING/EXTENDED-RELEASE INJECTABLES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 77 KEY PLAYERS PROVIDING FEED ADDITIVES
TABLE 78 GLOBAL VOLUME ANALYSIS OF FEED ADDITIVES, 2024–2031 (THOUSAND UNITS)
TABLE 79 FEED ADDITIVES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 80 OTHER ENDOPARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 81 EXAMPLES OF ENDECTOCIDES AVAILABLE IN MARKET
TABLE 82 ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 83 ENDECTOCIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 84 KEY PLAYERS PROVIDING ORAL ENDECTOCIDES
TABLE 85 GLOBAL VOLUME ANALYSIS OF ORAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)
TABLE 86 ORAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 87 KEY PLAYERS PROVIDING INJECTABLE ENDECTOCIDES
TABLE 88 GLOBAL VOLUME ANALYSIS OF INJECTABLE ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)
TABLE 89 INJECTABLE ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 90 KEY PLAYERS PROVIDING TOPICAL ENDECTOCIDES
TABLE 91 GLOBAL VOLUME ANALYSIS OF TOPICAL ENDECTOCIDES, 2024–2031 (THOUSAND UNITS)
TABLE 92 TOPICAL ENDECTOCIDES: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 93 ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 94 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 95 ANIMAL PARASITICIDES MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 96 ANIMAL PARASITICIDES MARKET FOR DOGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 97 ANIMAL PARASITICIDES MARKET FOR CATS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 98 ANIMAL PARASITICIDES MARKET FOR HORSES, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 99 PARASITICIDE APPLICATIONS ACROSS OTHER COMPANION ANIMAL SPECIES
TABLE 100 ANIMAL PARASITICIDES MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 101 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2024–2031 (USD MILLION)
TABLE 102 ANIMAL PARASITICIDES MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 103 ANIMAL PARASITICIDES MARKET FOR CATTLE, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 104 ANIMAL PARASITICIDES MARKET FOR PIG, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 105 ANIMAL PARASITICIDES MARKET FOR POULTRY, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 106 ANIMAL PARASITICIDES MARKET FOR SHEEP & GOAT, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 107 ANIMAL PARASITICIDES MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 108 ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 109 ANIMAL PARASITICIDES MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 110 ANIMAL PARASITICIDES MARKET FOR ANIMAL FARMS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 111 ANIMAL PARASITICIDES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 112 ANIMAL PARASITICIDES MARKET, BY REGION, 2024–2031 (USD MILLION)
TABLE 113 NORTH AMERICA: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
TABLE 114 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 115 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 116 NORTH AMERICA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 117 NORTH AMERICA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 118 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 119 NORTH AMERICA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 120 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 121 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 122 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 123 NORTH AMERICA: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 124 US: KEY MACROINDICATORS
TABLE 125 US: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 126 US: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 127 US: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 128 US: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 129 US: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 130 US: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 131 US: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 132 US: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 133 US: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 134 CANADA: KEY MACROINDICATORS
TABLE 135 CANADA: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 136 CANADA: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 137 CANADA: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 138 CANADA: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 139 CANADA: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 140 CANADA: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 141 CANADA: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 142 CANADA ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 143 CANADA ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 144 EUROPE: ANIMAL PARASITICIDES MARKET VOLUME ANALYSIS, BY PRODUCT TYPE, 2024–2031 (THOUSAND UNITS)
TABLE 145 EUROPE: ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
TABLE 146 EUROPE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 147 EUROPE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 148 EUROPE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 149 EUROPE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 150 EUROPE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 151 EUROPE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 152 EUROPE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 153 EUROPE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 154 EUROPE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 155 GERMANY: KEY MACROINDICATORS
TABLE 156 GERMANY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 157 GERMANY: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 158 GERMANY: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 159 GERMANY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 160 GERMANY: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 161 GERMANY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 162 GERMANY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 163 GERMANY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 164 GERMANY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 165 UK: KEY MACROINDICATORS
TABLE 166 UK: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 167 UK: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 168 UK: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 169 UK: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 170 UK: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 171 UK: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 172 UK: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 173 UK: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 174 UK ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 175 FRANCE: KEY MACROINDICATORS
TABLE 176 FRANCE: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 177 FRANCE: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 178 FRANCE: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 179 FRANCE: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 180 FRANCE: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 181 FRANCE: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 182 FRANCE: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 183 FRANCE: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 184 FRANCE: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 185 ITALY: KEY MACROINDICATORS
TABLE 186 ITALY: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 187 ITALY: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 188 ITALY: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 189 ITALY: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 190 ITALY: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 191 ITALY: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 192 ITALY: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 193 ITALY: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 194 ITALY: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 195 SPAIN: KEY MACROINDICATORS
TABLE 196 SPAIN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 197 SPAIN: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 198 SPAIN: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 199 SPAIN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 200 SPAIN: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 201 SPAIN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 202 SPAIN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 203 SPAIN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 204 SPAIN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 205 NETHERLANDS: KEY MACROINDICATORS
TABLE 206 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 207 NETHERLANDS: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 208 NETHERLANDS: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 209 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 210 NETHERLANDS: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 211 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 212 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 213 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 214 NETHERLANDS: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 215 SWEDEN: KEY MACRO INDICATORS
TABLE 216 SWEDEN: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 217 SWEDEN: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 218 SWEDEN: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 219 SWEDEN: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 220 SWEDEN: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 221 SWEDEN: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 222 SWEDEN: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 223 SWEDEN: ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 224 SWEDEN: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
TABLE 225 POLAND: KEY MACRO INDICATORS
TABLE 226 POLAND: ANIMAL PARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 227 POLAND: ECTOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 228 POLAND: ENDOPARASITICIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 229 POLAND: ANIMAL PARASITICIDES MARKET, BY INJECTABLE TYPE, 2024–2031 (USD MILLION)
TABLE 230 POLAND: ENDECTOCIDES MARKET, BY TYPE, 2024–2031 (USD MILLION)
TABLE 231 POLAND: ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2024–2031 (USD MILLION)
TABLE 232 POLAND: ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2024–2031 (USD MILLION)
TABLE 233 POLAND ANIMAL PARASITICIDES MARKET, BY LIVESTOCK ANIMAL, 2024–2031 (USD MILLION)
TABLE 234 POLAND: ANIMAL PARASITICIDES MARKET, BY END USER, 2024–2031 (USD MILLION)
The global animal parasiticides market was valued at $XX million in 2013 and is expected to reach $XX million by 2018, growing at a CAGR of XX% from 2013 to 2018. This market is consolidated in nature. The top five market players—Sanofi (France), Bayer AG (Germany), Zoetis, Inc. (U.S.), Novartis AG (Switzerland), and Merck & Co., Inc. (U.S.)—had a collective market share of nearly XX% in 2013. Some of the other leading players in the industry include Ceva Sante Animale (France), Virbac SA (France), Boehringer Ingelheim (Germany), and Vetoquinol (France). Together, the top 10 players accounted for approximately XX% of the global animal parasiticides market in 2013.
Currently, this market is driven by the rising concerns regarding zoonotic diseases, upsurge in the investment from government organizations, non-government agencies, leading market players, increasing demand for animal protein and animal-based food, and worldwide regulations for prevention of the spread of animal diseases. In addition, implementation of animal welfare acts in developed countries, broad spectrum of parasiticides product offerings by leading players, and upsurge in the adoption of pet animals are also expected to drive the sales volume of the animal parasiticides market during the forecast period.
In terms of geographic focus, the market will experience an increase in the high-growth developing markets across APAC and the RoW regions. Though Europe and North America commanded the largest share in the animal parasiticides market in 2013, the emerging countries in APAC and the RoW regions represent the fastest-growing markets due to the increasing livestock and companion animals population, increasing GDP rate, increase in per capita animal health expenditure, growing awareness about animal health among animal owners, and improving animal healthcare infrastructure.
Regulatory restrictions pose a major challenge for the growth of the global animal parasiticides market. In the developed countries there are stringent regulations for registration and approval of animal parasiticides which increases the cost and approval time for launching a new product in the market. Moreover, certain parasiticides are banned in some countries for use in certain animal categories.
Currently, the R&D investments in animal pharmaceuticals including parasiticides market are on rise. Mergers and acquisitions among key market players in the animal healthcare market have led to the consolidation of the market. Moreover, the market players are developing a broad spectrum of animal parasiticides products to combat the disease outbreaks in the animals, thereby protecting animal health. These represent the largest trends in the animal parasiticides market, attracting the largest share of innovation and investments in the industry.
The animal parasiticides market is broadly classified according to product type and animal type.
